ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 827,20
-0,38%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. Interleukin Genetics, (ILI)

  7. Interleukin Genetics, (ILI) Actualités

ILI

Interleukin Genetics (ILI)

Interleukin Genetics,
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:ILI
DateHeureSourceTitreSymboleSociété
12/08/201022h07Edgar (US Regulatory)Quarterly Report (10-Q)AMEX:ILIInterleukin Genetics,
05/08/201022h01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)AMEX:ILIInterleukin Genetics,
05/08/201014h49Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:ILIInterleukin Genetics,
05/08/201013h02Edgar (US Regulatory)Current report filing (8-K)AMEX:ILIInterleukin Genetics,
05/05/201012h02Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)AMEX:ILIInterleukin Genetics,
01/05/201001h09Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)AMEX:ILIInterleukin Genetics,
30/04/201019h15Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)AMEX:ILIInterleukin Genetics,
13/04/201023h04Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)AMEX:ILIInterleukin Genetics,
25/03/201021h13Edgar (US Regulatory)Annual Report (10-K)AMEX:ILIInterleukin Genetics,
10/03/201023h11Edgar (US Regulatory)Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)AMEX:ILIInterleukin Genetics,
09/03/201015h46Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)AMEX:ILIInterleukin Genetics,
05/03/201020h52Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(5) (424B5)AMEX:ILIInterleukin Genetics,
04/02/201013h00PR Newswire (US)Interleukin Genetics to Present at the 12th Annual BIO CEO ConferenceAMEX:ILI
19/01/201013h30PR Newswire (US)LABEC Pharma to Begin Selling Interleukin Genetics' Heart Health Genetic Test in EuropeAMEX:ILI
06/01/201016h44Edgar (US Regulatory)Prospectus filed pursuant to Rule 424(b)(2) (424B2)AMEX:ILIInterleukin Genetics,
06/01/201012h00Edgar (US Regulatory)Notice of Effectiveness (EFFECT)AMEX:ILIInterleukin Genetics,
17/12/200913h30PR Newswire (US)Interleukin Genetics Launches Bone Health Genetic Test to Identify Individuals at Higher Risk for Spine Fracture and Low Bone MiAMEX:ILI
07/12/200913h30PR Newswire (US)Interleukin Genetics Receives Approval To Sell its PST(R) Periodontal Disease Genetic Test in New YorkAMEX:ILI
02/12/200915h15PR Newswire (US)Interleukin Genetics and NYU Langone Medical Center Announce Publication of Study on Genetics of OsteoarthritisAMEX:ILI
12/11/200922h20PR Newswire (US)Interleukin Genetics Reports Third Quarter 2009 Financial ResultsAMEX:ILI
05/11/200913h00PR Newswire (US)Interleukin Genetics Announces Conference Call to Discuss Third Quarter 2009 ResultsAMEX:ILI
29/10/200912h00PR Newswire (US)Interleukin Genetics Enters Partnership Agreement with Amway Global to Sell Inherent Health Brand of Genetic TestsAMEX:ILI
13/10/200913h00PR Newswire (US)Interleukin Genetics to Present Research Findings at Upcoming Medical MeetingsAMEX:ILI
23/09/200913h00PR Newswire (US)Interleukin Genetics, Inc. Announces Positive Results from Clinical Study Evaluating Genetic Test's Impact on Weight LossAMEX:ILI
13/08/200922h20PR Newswire (US)Interleukin Genetics Reports Second Quarter 2009 Financial ResultsAMEX:ILI
06/08/200913h30PR Newswire (US)Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 ResultsAMEX:ILI
02/07/200913h00PR Newswire (US)Interleukin Genetics Announces Strategic Divestment of Alan James GroupAMEX:ILI
08/06/200915h00PR Newswire (US)Interleukin Genetics Launches Inherent Health Brand of Genetic Tests Offering Clear and Personalized Insights to WellnessAMEX:ILI
05/06/200920h00PR Newswire (US)Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual MeetingAMEX:ILI
15/05/200915h00PR Newswire (US)Interleukin Genetics to Present at the 2009 BIO Business ForumAMEX:ILI
 Showing the most relevant articles for your search:AMEX:ILI

Dernières Valeurs Consultées

USOTC
UMGP
Universal Media (PK)
ASX
OKR
Okapi Resources
AMEX
ESP
Espey Manufacturing and ...
UNSW
COMFIETH
CompliFi
BIT
UC4NHD
Unicredit Bank
BIT
UC4PP7
Unicredit Bank
NASDAQI
NUSB
Nuveen Ultra Short Incom...
BIT
UC5F61
Unicredit Bank
BITMOT
820023
Efsf Tf 0,5% Lg25 Eur
UNSW3
TITTERETH
Titter
BIT
UI328C
Unicredit Bank
BIT
I09249
Intesa Sanpaolo
NASDAQ
FHQZYX
Senior Loan And Dividend...
EU
EZMLG
Euronext Eurozone Large ...
FTSE
EB3510
FTSEurofirst 300 Eurozon...
COIN
BDTTUSD
Block Duelers
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés